Canada’s medical cannabis ambition no laughing matter
Growing acceptance of medical marijuana could see cannabis companies coming after pharma sales.
First-quarter acquisition activity lifts hopes for a big year
After a slow 2017, first-quarter biopharma acquisition activity could signal a turnaround.
